Will the category recover as restrictions ease?
Photo © Lecic - Stock.adobe.com
Weight-management dietary supplement sales have fallen since the COVID-19 pandemic began. Data from SPINS (Chicago) on the 52 weeks ending November 29, 2020, for instance, showed an 11% contraction in sales of weight-management supplement ingredients in the U.S. mainstream market, with 9 out of 10 ingredients in the category falling by double-digit percentages.1
Will the factors that prompted the segment’s contraction abate, and will weight-management ingredients start to see sales grow again as restrictions ease? What can prompt consumers to start purchasing these products? For clues, we look at some of the general market forces driving consumers’ weight-management behaviors.
Pandemic Prompts Weight Gain
With fitness centers closed and sports events cancelled, an increasing number of consumers are experiencing the “Quarantine 15” weight gain. Matt Olesiak, MD, chief medical director at SaneSolution (Spokane, WA), says that for months, many Americans haven’t had a safe place to exercise.
“Going for long walks or bike rides outside was an option, but it wasn’t feasible for many people,” Olesiak notes. “At the start of the pandemic, experts weren’t sure how COVID-19 was spread, leaving many people fearful of venturing outside. Forced inactivity combined with ‘stress eating’ has led to weight gain for many people during this pandemic.”
One October 2020 survey of 1,012 U.S. adults by research firm Kelton Global (Los Angeles, CA) and biotechnology firm Gelesis (Boston, MA) found that 29% of respondents have gained weight since the pandemic started. Kelton Global extrapolated this finding to estimate that 71 million Americans have packed on the pandemic pounds.2
Consumers Holding Their Dollars
The pandemic sent shockwaves through the world economy not seen since the bursting of the dotcom bubble in 2000. The U.S. Bureau of Labor Statistics found that, seasonally adjusted, the nationwide unemployment rate spiked from a 20-year low of 3.5% in January 2020 to a 20-year high of 14.8% in April 2020.3 While the unemployment rate has since decreased to 6.3% as of January 20214, Olesiak says many consumers are still being conservative with their finances in the aftermath of a severe economic shock. Moreover, he notes that many consumers are more concerned about their immediate survival amid a deadly pandemic than they are about weight gain.
Just as consumers hoarded their money in the five years following the 2008 Recession5, the economic crisis triggered by the pandemic has caused unprecedented levels of cash hoarding. In April 2020, Americans were saving 33% of their disposable income, the highest personal savings rate ever recorded since the Bureau of Economic Analysis started tracking that metric in the 1960s.6 While the personal savings rate has since fallen from this historic peak, it was still approximately double the usual average as of December 2020.7
Gradual Improvement?
Will the weight-management market recover from this contraction? The industry certainly hopes so. As more COVID-19 vaccines roll out and restrictions ease, the hope is that more consumers will seek to get active and lose the weight they gained during the pandemic, which hopefully will bring renewed interest in weight-management supplements. Until then, companies should work to stay top of mind and continue engaging with their audiences.
References
Kratom sees impressive sales growth despite its regulatory status and stigma
March 12th 2025Despite its controversy, kratom is a top-selling ingredient that consumers see value in. That said, brands need to work hard to demonstrate safety and quality of kratom products in the absence of legal regulatory status. Will kratom be able to overcome its stigma for even more growth and consumer acceptance?
DOJ asks Utah court to dismiss FTC lawsuit against Xlear Inc.
March 11th 2025On March 10, the DOJ and the defendant filed a stipulation to dismiss with prejudice the lawsuit in which each party agrees “to be responsible for its own costs and fees and agrees that no party shall be responsible to any other party for any fines, costs, fees, or penalties arising from this case.”
HHS announces efforts to eliminate independent conclusion of GRAS
Published: March 11th 2025 | Updated: March 11th 2025U.S. Department of Health and Human Services (HHS) Secretary, Robert F. Kennedy Jr., is directing the acting U.S. Food and Drug Administration’s (FDA) acting commissioner to explore rulemaking that would eliminate the independent conclusion of GRAS provision.